Notice Type
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Botulinum Toxin type A 100 units/vial Powder for reconstitution for IM injection Adria S P Inc., Albuquerque, New Mexico, United States of America Botox Fleroxacin 400 mg/100 ml Solution for infusion F Hoffmann-La Roche Limited, Basle, Switzerland Quinodis Fleroxacin 200 mg, 400 mg Tablets F Hoffmann-La Roche Limited, Basle, Switzerland Quinodis Methadone hydrochloride 5 mg Note: Not to be marketed as substitutable for any other methadone hydrochloride product as if the two (2) products were bioequivalent. Tablet Douglas Pharmaceuticals Limited, Technical Division, Mount Roskill, Auckland Pallidone Isosorbide dinitrate 5 mg Tablet (sub-lingual) Apotex Inc., Weston, Ontario, Canada APO-ISDN Paracetamol 500 mg, pseudoephedrine hydrochloride 30 mg, tripolidine hydrochloride 1.25 mg Tablet Wellcome Australia Limited, Cabarita, Sydney, New South Wales, Australia Sudafed Plus Nicorandil 10 mg, 20 mg Tablets E Merck, Darmstadt, Germany Sigmart Alginic acid 310 mg, calcium carbonate 500 mg, sodium bicarbonate 500 mg, aluminium hydroxide 400 mg, magnesium hydroxide 400 mg per 20 ml Oral suspension Parke Davis Pty Limited, Caringbah, New South Wales, Australia Remegel Liquid Paracetamol 300 mg, pseudoephedrine hydrochloride 30 mg Capsule Upjohn Pty Limited, Rydalmere, New South Wales, Australia Orthoxicol 2 Nasal Relief Glipizide 2.5 mg, 5 mg Tablets Alphapharm Pty Limited, Carole Park, Brisbane, Australia Glipid Pergolide mesylate 0.05 mg, 0.25 mg, 1 mg Tablets Eli Lilly and Company, Indianapolis, Indiana, United States of America Permax Dated this 21st day of October 1993. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Publication Date
28 Oct 1993

Notice Number


Page Number